| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 05/15/2013 | CN101707888B Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin |
| 05/15/2013 | CN101495486B Camptothecin derivatives with antitumor activity |
| 05/14/2013 | US8440820 Antioxidant inflammation modulators: oleanolic acid derivatives with saturation in the C-ring |
| 05/14/2013 | US8440654 Thieno- and furo-pyrimidine modulators of the histamine H4 receptor |
| 05/14/2013 | CA2716369C Phenoxypropylamine compounds |
| 05/14/2013 | CA2611889C Substituted tetrahydroquinolines |
| 05/10/2013 | WO2013067267A1 Rod -like hepatitis c virus inhibitors containing the fragement {2- [4- (bi phenyl - 4 - yl) - 1h - imidazo - 2 - yl] pyrrolidine - 1 - carbonlymethyl} amine |
| 05/10/2013 | WO2013065825A1 Cationic lipid |
| 05/10/2013 | WO2013064128A1 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
| 05/10/2013 | WO2013064083A1 1-(arylmethyl)-5,6,7,8-tetrahydroquinazoline-2,4-diones and analogs and the use thereof |
| 05/10/2013 | WO2013064068A1 Thienopyrimidine and furopyrimidine derivatives, preparation method thereof and medical use thereof |
| 05/10/2013 | WO2012158413A3 Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors |
| 05/10/2013 | CA2854083A1 Methods of preparing icotinib and icotinib hydrochloride, and intermediates thereof |
| 05/10/2013 | CA2854066A1 Cationic lipid |
| 05/10/2013 | CA2852700A1 Rod-like hepatitis c virus inhibitors containing the fragment {2-[4-(biphenyl-4-yl)-1h-imidazo-2-yl]pyrrolidine-1-carbonlymethyl}amine |
| 05/09/2013 | US20130116436 Process for preparing pyrano - [2,3-c]pyridine derivitaves |
| 05/09/2013 | US20130116297 Novel fusarisetin compounds, and use thereof |
| 05/09/2013 | US20130116275 Inhibitors of hif and angiogenesis |
| 05/09/2013 | US20130116233 Novel inhibitor compounds of phosphodiesterase type 10a |
| 05/09/2013 | US20130116230 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 05/09/2013 | US20130116213 Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity |
| 05/09/2013 | US20130115194 Hepatitis c virus inhibitors |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588471A1 Heterocyclic compounds and their use as inhibitors of pi3k activity |
| 05/08/2013 | EP2021344B1 Bicyclic enamino(thio)carbonyl compounds |
| 05/08/2013 | CN103098253A Organic electroluminescent element |
| 05/08/2013 | CN103097391A Novel spiroheterocyclic compounds as mGlu5 antagonists |
| 05/08/2013 | CN103097364A Spiro-Cyclic Amine Derivatives as S1P Modulators |
| 05/08/2013 | CN103087078A Thienopyridine and furopyridine kinase inhibitors |
| 05/08/2013 | CN103087077A Thienopyrimidine and furopyrimidine derivative, its preparation method and application in medicines |
| 05/08/2013 | CN103087072A (+)-Tricyclic hydroxy lactone preparation method |
| 05/08/2013 | CN103087071A Preparation method of Cu (2+) color indicator based on rhodamine B-2-formaldehyde thiophene derivative |
| 05/08/2013 | CN103087070A Preparation method for high-purity nitidine chloride as well as quality control method of high-purity nitidine chloride |
| 05/08/2013 | CN103087068A Condensed-cyclic Compound And Organic Light-emitting Device Including The Same |
| 05/08/2013 | CN103087024A Flavone alkylamine compounds as well as preparation method and application thereof |
| 05/08/2013 | CN101965382B Synthetic resin composition, and automotive interior/exterior material comprising the same |
| 05/08/2013 | CN101574084B 螺二氢吲哚哌啶衍生物 Spiroindoline piperidine derivative |
| 05/07/2013 | US8436170 Xanthene dyes comprising a sulfonamide group |
| 05/07/2013 | US8436104 Polymer |
| 05/07/2013 | US8435549 Halogen alkoxy spirocyclic tetramic and tetronic acid derivatives |
| 05/07/2013 | CA2568752C Novel unsaturated tetracyclic tetrahydrofuran derivatives |
| 05/02/2013 | WO2013063549A1 Substituted 2-(4-heterocyclylbenzyl)isoindolin-1-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m1 |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | US20130109713 Antimicrobial agents |
| 05/02/2013 | US20130109711 Novel compounds |
| 05/02/2013 | US20130109698 Small Molecule Inhibitors of Functions of the HIV-1 Matrix Protein |
| 05/02/2013 | US20130109679 Heterocyclic compounds containing an indole core |
| 05/02/2013 | US20130109670 Triazine compounds as pi3 kinase and mtor inhibitors |
| 05/02/2013 | US20130108583 Methods of use for cyclopamine analogs |
| 05/02/2013 | US20130108582 Methods of use of cyclopamine analogs |
| 05/02/2013 | US20130105769 Condensed-cyclic compound and organic light-emitting device including the same |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/01/2013 | EP2586781A1 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 05/01/2013 | EP2585447A2 Compounds and methods for the treatment or prevention of flavivirus infections |
| 05/01/2013 | CN103080106A Cyclic ether compounds useful as kinase inhibitors |
| 05/01/2013 | CN103073557A Benzophenanthridine alkaloid and application of benzophenanthridine alkaloid in resisting cardiovascular system diseases |
| 05/01/2013 | CN103073556A Synthesis method for (RS)-2-(10-hydrogen-9-oxa-1-acridine-6-group) propionic acid degradation impurity |
| 05/01/2013 | CN103073555A Synthesis method for (RS)-2-(10-hydrogen-9-oxa-1-acridine-6-group) propionic acid degradation impurity |
| 05/01/2013 | CN103073554A Substituted pyrrole chromone compound |
| 05/01/2013 | CN103073460A Arylsulfonylmethyl or arylsulfonamide substituted aromatic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 05/01/2013 | CN102046667B Novel compound, polymerizable composition, color filter and process for produciton thereof, solid-state imaging element, and lithographic printing original plate |
| 05/01/2013 | CN101657430B Organic compounds and their uses |
| 05/01/2013 | CN101631792B Novel phosphodi esterase inhibitors |
| 05/01/2013 | CN101056852B Iodine-phenyl-substituted cyclic cetoenols |
| 04/30/2013 | US8431698 Bioluminescent endoscopy methods and compounds |
| 04/30/2013 | US8431574 Heterocyclic inhibitors of MEK and methods of use thereof |
| 04/30/2013 | US8431573 Cyanopyrimidinones |
| 04/30/2013 | US8431566 Cyclopamine lactam analogs and methods of use thereof |
| 04/30/2013 | US8431564 Ring-annulated dihydropyrrolo[2,1-α]isoquinolines |
| 04/30/2013 | US8431563 Compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 04/30/2013 | CA2687614C Methods for preparing diazonamides |
| 04/30/2013 | CA2673249C 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections |
| 04/30/2013 | CA2582180C Indazoles, benzisoxazoles and benzisothiazoles, process for preparing them, pharmaceutical compositions and use as estrogenic agents |
| 04/25/2013 | WO2013005168A3 Cannabinoid receptor modulators |
| 04/25/2013 | US20130102621 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
| 04/25/2013 | US20130102620 Pyrazolopyrimidine derivative |
| 04/25/2013 | US20130102604 Novel cyclopropane indolinone derivatives |
| 04/25/2013 | US20130102603 2,4-diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| 04/25/2013 | US20130102600 Heteroaryl hydroxamic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease |
| 04/25/2013 | US20130102587 New Enzyme Inhibitor Compounds |
| 04/24/2013 | EP2583956A2 A method of preparation of polycyclic, fused aromatic and heteroaromatic hydrocarbons and intermediates |
| 04/24/2013 | EP2582706A1 3-oxo-3,9-dihydro-1h-chromeno[2,3-c]pyrroles as glucokinase activators |
| 04/24/2013 | EP2582705A1 Anellated pyridine compounds as dual modulators of the 5-ht2a and d3 receptors |
| 04/24/2013 | EP2582704A2 Asenapine maleate |
| 04/24/2013 | CN103068827A Fused heterocyclic derivatives as s1p modulators |
| 04/24/2013 | CN103059035A Application of composition of fugu extract, evening primrose oil and flax seed oil to toxin removal of human body |
| 04/24/2013 | CN103059034A Methods for synthesizing securinine natural products flueggine A, norsecurinine, virosaine B and allonorsecurinine |
| 04/24/2013 | CN103059017A Design of comprehensive extraction process for barberry plant resources |
| 04/24/2013 | CN103054904A Application of composition of fugu total extract alkaloids and grease to synergism of analgesic drug |
| 04/24/2013 | CN102137679B Isolation of cyclopamine |
| 04/24/2013 | CN102046634B Production method for camptothecin derivative |
| 04/23/2013 | US8426440 Indolymaleimide derivatives |
| 04/23/2013 | US8426436 Heterocyclic cyclopamine analogs and methods of use thereof |
| 04/23/2013 | CA2471355C Substituted diketopiperazines as oxytocin antagonists |
| 04/18/2013 | WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| 04/18/2013 | WO2013054108A1 Mono-fluoro beta-secretase inhibitors |
| 04/18/2013 | WO2013053051A1 Indazole compounds as kinase inhibitors and method of treating cancer with same |
| 04/18/2013 | WO2013020184A9 Flavonoid compounds, and methods of use thereof |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
| 04/18/2013 | US20130096300 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol |